One‐Step Generation of a Drug‐Releasing Hydrogel Microarray‐On‐A‐Chip for Large‐Scale Sequential Drug Combination Screening

Abstract Large‐scale screening of sequential drug combinations, wherein the dynamic rewiring of intracellular pathways leads to promising therapeutic effects and improvements in quality of life, is essential for personalized medicine to ensure realistic cost and time requirements and less sample consumption. However, the large‐scale screening requires expensive and complicated liquid handling systems for automation and therefore lowers the accessibility to clinicians or biologists, limiting the full potential of sequential drug combinations in clinical applications and academic investigations. Here, a miniaturized platform for high‐throughput combinatorial drug screening that is “pipetting‐free” and scalable for the screening of sequential drug combinations is presented. The platform uses parallel and bottom‐up formation of a heterogeneous drug‐releasing hydrogel microarray by self‐assembly of drug‐laden hydrogel microparticles. This approach eliminates the need for liquid handling systems and time‐consuming operation in high‐throughput large‐scale screening. In addition, the serial replacement of the drug‐releasing microarray‐on‐a‐chip facilitates different drug exchange in each and every microwell in a simple and highly parallel manner, supporting scalable implementation of multistep combinatorial screening. The proposed strategy can be applied to various forms of combinatorial drug screening with limited amounts of samples and resources, which will broaden the use of the large‐scale screening for precision medicine.

[1]  E. Winer,et al.  International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy , 2009, Journal of the National Cancer Institute.

[2]  Su Deok Kim,et al.  An encoded viral micropatch for multiplex cell-based assays through localized gene delivery. , 2017, Lab on a chip.

[3]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[4]  Julio Saez-Rodriguez,et al.  A microfluidics platform for combinatorial drug screening on cancer biopsies , 2018, Nature Communications.

[5]  U. Schepers,et al.  Fish‐Microarray: A Miniaturized Platform for Single‐Embryo High‐Throughput Screenings , 2018 .

[6]  Sridhar Ramaswamy,et al.  Patient-derived models of acquired resistance can identify effective drug combinations for cancer , 2014, Science.

[7]  P. Sorger,et al.  Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.

[8]  Jesper Ferkinghoff-Borg,et al.  Dynamic Rearrangement of Cell States Detected by Systematic Screening of Sequential Anticancer Treatments. , 2017, Cell reports.

[9]  P. Levkin,et al.  Droplet Microarray Based on Patterned Superhydrophobic Surfaces Prevents Stem Cell Differentiation and Enables High‐Throughput Stem Cell Screening , 2017, Advanced healthcare materials.

[10]  Jiyun Kim,et al.  One-step pipetting and assembly of encoded chemical-laden microparticles for high-throughput multiplexed bioassays , 2014, Nature Communications.

[11]  E. Scott,et al.  Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells , 2015, Proceedings of the National Academy of Sciences.

[12]  G. Schwartz,et al.  Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  G. Lahav,et al.  Schedule-dependent interaction between anticancer treatments , 2016, Science.

[14]  P. Majumder,et al.  Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition , 2015, Nature Communications.

[15]  B. Stillman,et al.  Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug , 2009, Nature Biotechnology.

[16]  Daewon Lee,et al.  Liquid-capped encoded microcapsules for multiplex assays. , 2017, Lab on a chip.

[17]  B. Lindgren,et al.  Sequential therapy with sorafenib and sunitinib in renal cell carcinoma , 2007, Cancer.

[18]  F. Mandelli,et al.  Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. , 2006, Cancer research.

[19]  G. Pan,et al.  Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT–MET mechanism for optimal reprogramming , 2013, Nature Cell Biology.

[20]  David Beebe,et al.  Engineers are from PDMS-land, Biologists are from Polystyrenia. , 2012, Lab on a chip.

[21]  Luke P. Lee,et al.  Single-cell enzyme concentrations, kinetics, and inhibition analysis using high-density hydrodynamic cell isolation arrays. , 2006, Analytical chemistry.

[22]  P. Levkin,et al.  Droplet Microarrays: From Surface Patterning to High‐Throughput Applications , 2018, Advanced materials.

[23]  Yuhui Liu,et al.  Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells , 2000, Journal of neurochemistry.

[24]  Christos Hatzis,et al.  Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. , 2017, Cancer research.

[25]  A. Manz,et al.  Revisiting lab-on-a-chip technology for drug discovery , 2012, Nature Reviews Drug Discovery.

[26]  Shoji Takeuchi,et al.  A dynamic microarray device for paired bead-based analysis. , 2010, Lab on a chip.

[27]  P. Levkin,et al.  Droplet‐Array (DA) Sandwich Chip: A Versatile Platform for High‐Throughput Cell Screening Based on Superhydrophobic–Superhydrophilic Micropatterning , 2015, Advanced materials.

[28]  John Calvin Reed,et al.  A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. , 1998, British Journal of Cancer.

[29]  S. Vilar,et al.  High-Throughput Methods for Combinatorial Drug Discovery , 2013, Science Translational Medicine.

[30]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[31]  Sudeok Kim,et al.  Uniform Drug Loading into Prefabricated Microparticles by Freeze‐Drying , 2017 .